{"name":"RA Capital Management","permalink":"ra-capital-management","crunchbase_url":"http://www.crunchbase.com/financial-organization/ra-capital-management","homepage_url":"http://www.racap.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617-778-2509","description":"","email_address":"adaniels@racap.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Sat Apr 24 05:30:14 UTC 2010","updated_at":"Sat Apr 24 05:37:31 UTC 2010","overview":"<p>RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. Their team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and board levels. They invest in companies with promising technologies and products. Their approach is to achieve a superior understanding of data, experimental/trial design, regulatory process, and commercial potential. When appropriate, they can offer their portfolio companies leads on in-licensing opportunities and strategic partnerships, as well as insight into the demands of the public markets.</p>","image":{"available_sizes":[[[150,19],"assets/images/resized/0008/4805/84805v1-max-150x150.jpg"],[[250,31],"assets/images/resized/0008/4805/84805v1-max-250x250.jpg"],[[337,43],"assets/images/resized/0008/4805/84805v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"20 Park Plaza","address2":"Suite 905","zip_code":"02116","city":"Boston","state_code":"MA","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":8300000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":27,"company":{"name":"Genelabs Technologies","permalink":"genelabs-technologies","image":{"available_sizes":[[[150,39],"assets/images/resized/0005/9344/59344v1-max-150x150.jpg"],[[162,43],"assets/images/resized/0005/9344/59344v1-max-250x250.jpg"],[[162,43],"assets/images/resized/0005/9344/59344v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/t2-biosystems-inc-series-c-15m/","source_description":"T2 Biosystems, Inc.: Series C $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":26,"company":{"name":"T2 Biosystems","permalink":"t2-biosystems","image":{"available_sizes":[[[150,31],"assets/images/resized/0008/5037/85037v1-max-150x150.jpg"],[[250,53],"assets/images/resized/0008/5037/85037v1-max-250x250.jpg"],[[325,69],"assets/images/resized/0008/5037/85037v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/adventrx-announces-225m-capital-raise-mulls-acquisition/2011-01-07?utm_medium=rss&utm_source=rss","source_description":"Adventrx announces $22.5M capital raise","raised_amount":22500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":7,"company":{"name":"ADVENTRX Pharmaceuticals","permalink":"adventrx-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0011/6803/116803v1-max-150x150.jpg"],[[176,50],"assets/images/resized/0011/6803/116803v1-max-250x250.jpg"],[[176,50],"assets/images/resized/0011/6803/116803v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.masshightech.com/stories/2011/08/08/daily30-T2-Biosystems-closes-23M-Series-D-financing.html","source_description":"T2 Biosystems closes $23M Series D financing","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":10,"company":{"name":"T2 Biosystems","permalink":"t2-biosystems","image":{"available_sizes":[[[150,31],"assets/images/resized/0008/5037/85037v1-max-150x150.jpg"],[[250,53],"assets/images/resized/0008/5037/85037v1-max-250x250.jpg"],[[325,69],"assets/images/resized/0008/5037/85037v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ovascience-grabs-37m-b-round-fertility-treatments/2012-04-03","source_description":"OvaScience grabs $37M B round for fertility treatments","raised_amount":37000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":3,"company":{"name":"OvaScience","permalink":"ovascience","image":{"available_sizes":[[[150,42],"assets/images/resized/0015/7778/157778v3-max-150x150.jpg"],[[250,70],"assets/images/resized/0015/7778/157778v3-max-250x250.jpg"],[[331,93],"assets/images/resized/0015/7778/157778v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://in.finance.yahoo.com/news/bluebird-bio-secures-60-million-103000423.html","source_description":"bluebird bio Secures $60 Million in Oversubscribed Financing","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":25,"company":{"name":"bluebird bio","permalink":"genetix-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0169/80169v2-max-150x150.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-250x250.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}